Skip to main content

Breadcrumb

  1. Home

Endorsed

Anti-Lipid Treatment Discharge

Percent of patients aged 18 years and older undergoing isolated CABG who were discharged on a lipid lowering statin

CBE ID
0118

Appropriate Treatment for Children With Upper Respiratory Infection (URI)

The Appropriate Treatment for Upper Respiratory Infection (URI) measure assesses whether members 3 months of age and older with a diagnosis of upper respiratory infection were not dispensed an antibiotic prescription. The measure includes patients enrolled in commercial, Medicaid, and Medicare health plans.

CBE ID
0069

Asthma Medication Ratio

The percentage of patients 5–64 years of age who were identified as having persistent asthma and had a ratio of controller medications to total asthma medications of 0.50 or greater during the measurement year.

CBE ID
1800

Avoid Hospitalization After Release with a Misdiagnosis—ED Stroke/Dizziness (Avoid H.A.R.M.—ED Stroke/Dizziness)

This outcome measure tracks the rate of adult patients (aged 18 years and older) treated and released from the Emergency Department (ED) with either a non-specific, presumed benign symptom-only dizziness diagnosis or a specific inner ear/vestibular diagnosis (collectively referred to as “benign dizziness”) who were subsequently admitted to a hospital for a stroke within 30 days of their ED visit.

CBE ID
3746